Lv1
60 积分 2025-05-05 加入
Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder
9天前
已完结
Central Nervous System Post-transplant Lymphoproliferative Disorder: Response to Ibrutinib
13天前
已完结
Intrathecal Rituximab for EBV-Associated Post-Transplant Lymphoproliferative Disorder with Central Nervous System Involvement Unresponsive to Intravenous Rituximab-Based Treatments: A Prospective Study
13天前
已完结
Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
13天前
已完结
Favorable Outcome of Allogenic Stem Cell Transplant in Patients with Acute Myeloid Leukemia Carrying t(6;9)(p22;q34) / DEK-NUP214 Rearrangement
3个月前
已关闭
Favorable Outcome of Allogenic Stem Cell Transplant in Patients with Acute Myeloid Leukemia Carrying t(6;9)(p22;q34) / DEK-NUP214 Rearrangement
3个月前
已关闭
Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
7个月前
已完结
Ruxolitinib–ECP combination treatment for refractory severe chronic graft-versus-host disease
7个月前
已完结
Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
7个月前
已完结
皖公网安备34019202002308
